Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
Joint Authors
De Wilde, R. L.
Sänger, Nicole
Rabe, Thomas
Ebert, Andreas D.
Roemer, Thomas
Wallwiener, Markus
Tinneberg, H. R.
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-11-28
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate” [1], the affiliation of the third author was incorrect.
The corrected affiliation is shown above.
In addition, the Conflicts of Interest section should be updated as follows:
American Psychological Association (APA)
Rabe, Thomas& Sänger, Nicole& Ebert, Andreas D.& Roemer, Thomas& Tinneberg, H. R.& De Wilde, R. L.…[et al.]. 2018. Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”. BioMed Research International،Vol. 2018, no. 2018, pp.1-1.
https://search.emarefa.net/detail/BIM-1127708
Modern Language Association (MLA)
Rabe, Thomas…[et al.]. Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”. BioMed Research International No. 2018 (2018), pp.1-1.
https://search.emarefa.net/detail/BIM-1127708
American Medical Association (AMA)
Rabe, Thomas& Sänger, Nicole& Ebert, Andreas D.& Roemer, Thomas& Tinneberg, H. R.& De Wilde, R. L.…[et al.]. Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-1.
https://search.emarefa.net/detail/BIM-1127708
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1127708
